Literature DB >> 15913853

Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2.

Kevin W Bruhn1, Noah Craft, Bidong D Nguyen, Jimmy Yip, Jeff F Miller.   

Abstract

A potential approach to activate tumor-specific T cells is to use live bacterial vectors to deliver appropriate antigens in a highly immunostimulatory context. We constructed a recombinant strain of Listeria monocytogenes (rLM) expressing murine tyrosinase-related protein-2 (TRP-2), a nonmutated melanocyte-derived differentiation antigen highly expressed in melanomas. Immunization of C57Bl/6 mice with this rLM strain efficiently primed CD8 T cells to recognize the MHC class I-restricted TRP-2180-188 epitope and express IFN-gamma upon in vitro peptide stimulation. Peptide-loaded target cells were lysed in vitro by TRP-2-specific T cells in cytotoxicity assays, and mice immunized and boosted with rLM expressing TRP-2 were functionally protected from subcutaneous challenge with B16 melanoma cells. These results identify and characterize the anti-"self" T-cell responses induced by recombinant L. monocytogenes expressing an endogenous, nonmutated tumor antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913853     DOI: 10.1016/j.vaccine.2005.02.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.

Authors:  Gang Xin; David M Schauder; Ryan Zander; Weiguo Cui
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

2.  Bioluminescent imaging of melanoma in live mice.

Authors:  Noah Craft; Kevin W Bruhn; Bidong D Nguyen; Robert Prins; Linda M Liau; Eric A Collisson; Abhijit De; Michael S Kolodney; Sanjiv S Gambhir; Jeff F Miller
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

3.  Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.

Authors:  Zachary T Morrow; Zachary M Powers; John-Demian Sauer
Journal:  Curr Clin Microbiol Rep       Date:  2019-11-20

4.  An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.

Authors:  Matthew M Seavey; Paulo C Maciag; Nada Al-Rawi; Duane Sewell; Yvonne Paterson
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

Authors:  Dan D Vo; Robert M Prins; Jonathan L Begley; Timothy R Donahue; Lilah F Morris; Kevin W Bruhn; Pilar de la Rocha; Meng-Yin Yang; Stephen Mok; Hermes J Garban; Noah Craft; James S Economou; Francesco M Marincola; Ena Wang; Antoni Ribas
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

6.  KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

Authors:  Mojca Skoberne; Alice Yewdall; Keith S Bahjat; Emmanuelle Godefroy; Peter Lauer; Edward Lemmens; Weiqun Liu; Will Luckett; Meredith Leong; Thomas W Dubensky; Dirk G Brockstedt; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

7.  Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.

Authors:  Qingmei Jia; Bai-Yu Lee; Daniel L Clemens; Richard A Bowen; Marcus A Horwitz
Journal:  Vaccine       Date:  2009-01-04       Impact factor: 3.641

Review 8.  Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.

Authors:  Laurence M Wood; Yvonne Paterson
Journal:  Front Cell Infect Microbiol       Date:  2014-05-12       Impact factor: 5.293

9.  Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis.

Authors:  Jeevanathan Kalyanasundram; Suet Lin Chia; Adelene Ai-Lian Song; Abdul Rahim Raha; Howard A Young; Khatijah Yusoff
Journal:  BMC Biotechnol       Date:  2015-12-29       Impact factor: 2.563

10.  Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigen.

Authors:  Farah R Itani; Sushmita Sinha; Ashley A Brate; Lecia L Pewe; Katherine N Gibson-Corley; John T Harty; Nitin J Karandikar
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.